Centiva Capital »

Halozyme Therapeutics shares owned by Centiva Capital

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Centiva Capital

Quarter filed Position value Share count Share price at filing
2023-06-30 $10M 13M 0.84
2023-03-31 $7.4M 8.7M 0.85
2022-03-31 $2.6M 3.0M 0.88

More positions owned by Centiva Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr National Mun Etf (MUB)
Ishares Tr 1 3 Yr Treas Bd Call Option (SHY)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
stock
Simon Property Call Option (SPG)
Agnc Invt Corp Com reit Call Option (AGNC)
Advanced Micro Devices (AMD)
Citigroup Com New Call Option (C)

View all positions for Centiva Capital

Top funds holding Halozyme Therapeutics

Wellesley Investment Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Citigroup
Aviva
Citadel Advisors
D. E. Shaw & Co
Wells Fargo & Company
Readystate Asset Management
Tenor Capital Management
Wolverine Asset Management
Victory Capital Management
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management

View all funds holding Halozyme Therapeutics